PubRank

Prevention of Tuberculosis in Prisons

Clinical Trial ID NCT03028129

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03028129

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014 26.76
2 Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 1997 15.25
3 A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 2002 13.50
4 inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994 11.22
5 The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009 8.13
6 Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011 6.14
7 Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006 4.63
8 Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013 3.89
9 New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011 3.46
10 Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000 3.07
11 The WHO 2014 global tuberculosis report--further to go. Lancet Glob Health 2015 2.97
12 Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010 2.96
13 Tuberculosis control in the era of HIV. Nat Rev Immunol 2005 2.40
14 The host immune response to tuberculosis. Am J Respir Crit Care Med 1998 2.35
15 Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds. Am Rev Tuberc 1952 2.13
16 Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS One 2008 1.92
17 Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet 1997 1.91
18 The history of tuberculosis. Respir Med 2006 1.70
19 Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proc Natl Acad Sci U S A 2012 1.52
20 Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database Syst Rev 2013 1.46
21 Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. West J Med 1993 1.46
22 Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 1997 1.29
23 The chemical approach to the control of tuberculosis. Science 1952 1.25
24 Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics. Am J Trop Med Hyg 2011 1.15
25 Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development. Annu Rev Pharmacol Toxicol 2009 1.08
26 Tuberculosis and HIV infection among female inmates in São Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996 1.05
27 Tuberculosis in a southern Brazilian prison. Mem Inst Oswaldo Cruz 2012 1.05
28 Old and new selective pressures on Mycobacterium tuberculosis. Infect Genet Evol 2011 1.04
29 The re-emergence of tuberculosis. Annu Rev Public Health 1994 1.03
30 Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study. BMC Infect Dis 2015 1.03
31 Active and latent tuberculosis in prisoners in the Central-West Region of Brazil. Rev Soc Bras Med Trop 2013 1.01
32 Isoniazid preventive therapy in correctional facilities: a systematic review. Int J Tuberc Lung Dis 2012 0.99
33 Development and evaluation of tuberculosis screening scores in Brazilian prisons. Public Health 2006 0.99
34 Community isoniazid prophylaxis program in an underdeveloped area of Alaska. Public Health Rep 1967 0.98
35 Tuberculosis and latent tuberculosis in prison inmates. Rev Saude Publica 2011 0.92
36 The Impact of Ventilation and Early Diagnosis on Tuberculosis Transmission in Brazilian Prisons. Am J Trop Med Hyg 2015 0.90
37 Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis 2015 0.88
38 X ray screening at entry and systematic screening for the control of tuberculosis in a highly endemic prison. BMC Public Health 2013 0.85
39 Prevalence of patients with respiratory symptoms through active case finding and diagnosis of pulmonary tuberculosis among prisoners and related predictors in a jail in the city of Carapicuíba, Brazil. Rev Bras Epidemiol 2010 0.84
40 Health-service performance of TB treatment for indigenous and non-indigenous populations in Brazil: a cross-sectional study. BMC Health Serv Res 2014 0.83
41 Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid. Stanford Med Bull 1952 0.81
42 Rifapentine: its role in the treatment of tuberculosis. Ann Pharmacother 1999 0.75
Next 100